VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹33.90 | ₹21.31 | ₹19.87 | ₹30.47 | ₹50.04 |
What is the latest Earnings Per Share (EPS) of VENUS REMEDIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹33.90 |
| Mar2025 | ₹21.31 |
| Mar2024 | ₹19.87 |
| Mar2023 | ₹30.47 |
| Mar2022 | ₹50.04 |
How is Earnings Per Share (EPS) of VENUS REMEDIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹33.90 | 59.08 | |
| Mar2025 | ₹21.31 | 7.25 | |
| Mar2024 | ₹19.87 | -34.79 | |
| Mar2023 | ₹30.47 | -39.11 | |
| Mar2022 | ₹50.04 | - | |
Compare Earnings Per Share (EPS) of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,177.7 Cr | -4.5% | 5.1% | 216.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -4.5% |
5.1% |
216.6% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses